PERSONAL DETAILS: CURRICULUM VITAE NAME: RAHAL, MOHAMED MARITAL STATUS: ADDRESS: Married, 3 children King Fahad Specialist Hospital Oncology Department PO BOX 14563 DAMMAM 31434 Kingdom of Saudi Arabia Tel: 00966-503109035 Email: moharahal@hotmail.com CITIZENSHIP: Algerian American Green card holder LICENSE TO PRACTICE: Algeria 1979 France 1979 Saudi Arabia: 1995
HOSPITAL APPOINTMENTS: Fellow in Radiation /Oncology, Tenon Hospital, Paris, France 1979-1980 Fellow in Radiation /Oncology, Institut Gustave Roussy, Paris, France 1980-1982 Medical and Radiation Oncologist Staff Physician, Benbadis University Hospital, Constantine, Algeria 1979-1991 Department Chairman, Oncology Department, Benbadis University Hospital, Constantine 1992-1995 Medical Oncologist, King Faisal Specialist Hospital Riyadh Saudi Arabia: 1995- Oct 2005 Medical Oncologist, King Fahad Specialist Hospital Dammam Saudi Arabia: Nov 2005-2011 Section Head Adult Medical Oncology KFSH-Dammam Jan 2012- April 2013 Deputy Chairman Medical Oncology KFSH-Dammam May 2013-Present BOARD CERTIFICATION: Algerian Board in Radiation Oncology, Algiers, Algeria 1980 Qualifying Certificate in Head and Neck Oncology, Paris, France 1982 French Board Radiation-Oncology, Strasbourg, France 1982 Qualifying Certificate in Stem Cell Transplantation, Vienna, Austria 1997 European Certification in Medical Oncology, Switzerland, 2006 European Recertification in Medical Oncology, Switzerland, 2011 POST SPECIALTY STUDIES: Qualifying Certificate in Head and Neck Oncology, Paris, France 1982
Qualifying certificate in Stem Cell Transplantation, Vienna, Austria 1997 Diploma in Neuro Endocrine Tumors, Uppsala, Sweden 2010 ASCO-ESMO Cancer Research Workshop, Alahsa, 2012 ESMO Preceptorship on Neuro Endocrine Tumors, Singapore 2014 ADVISORY BOARD: Aventis Middle East Advisory board in breast cancer, Paris Feb 2007 Renal Cell Carcinoma workshop Expert, Paris, France 2011 Aventis Colorectal Advisory Board, Riyadh Feb 2013 LANGUAGE: Arabic, French, English: Proficient in conversation, reading and writing. MEMBERSHIPS IN PROFESSIONAL AND SCIENTIFIC SOCIETIES: American Society of Clinical Oncology 1988 International Nasopharyngeal Cancer Study Group 1989 European Society of Medical Oncology 2001 American Academy of Hospice and Palliative Care 2008 Member of Rare Cancer Network 2010 European Neuro Endocrine Tumor Society : ENETS 2011
MANUSCRIPTS :2008-Onwards 1- M. Rahal, E.Hassan, S Shakir, A Meshikhes, H Ramadan,S. EL Hady, A.AlMulla, F.AlManaa,A.Abdewarith, A,Alfaraj. What is the optimal duration of FOLFOX-Bevacizumab in metastatic colorectal cancer (Mcrc)? 6 th international symposium on targeted anti cancer therapies. Bethesda, USA, March 2008. 2- S. Akhtar, A.ElWeshi, M. Rahal,M.Abdelsalam, High dose chemotherapy and autologous stem cell transplant for relapsed or refractory Hodgkin's lymphoma in 58 adolescent patients. Evaluation of prognostic factors and their impact on survival. EBMT 2009, Abs,985 3- M. Rahal, A.Abdewarith, E.Hassan, S.Deo,H.Ramadan, N.AlNaimy. N.AlEissa.. HER - 2 positive locally advanced breast cancer one or two entities? ESMO 2009, Abs 5085. 4-M.Rahal, H.Ramadan,E Hassan,A. Arini, H. Mosleh, A. Abdelwarith, E.Senan, N.Al Naimy, A.AlFaraj, H.Halawani. Neoadjuvant platinum containing regimen for locally advanced triple negative breast cancer. Ann Onc vol 21,Supp 8,114, 2010. 5- M.Rahal, H.Abdullah,, H.Halawani, H.Zagloul, A. AlBuali, A.AlFaraj, E Hassan, H.Abdulkhalek, A Ahluwalia, F.Medhat. Plasma EBV-DNA concentration correlates with FDG-EBV in nasopharyngeal cancer treated with induction chemotherapy.ann Onc 1028, 2012, 23 ( suppl 9)
RESEARCH PROTOCOLS : 1. Bazarbashi S, Rahal M, Manji M, Isbester W. A pilot trial of preoperative chemoradiotherapy using Capecitabine (Xeloda) and external beam radiation followed by definitive surgery in patients with localized (non-metastatic rectal cancer). 2. Ezzat A, Rahal M. Phase II study of neoadjuvant chemotherapy with Doxorubicin followed by Docetaxel-Cisplatin in locally advanced breast cancer. 3. Bazarbashi S, Raja M, Rahal M. Phase II trial of concurrent administration of intravesical BCG and interferon α-2b in the treatment and prevention of recurrence of superficial TCC of the urinary bladder. 4. M.Rahal, S Akhtar,S Bazarbashi, I Maghfoor, TTweigeri, D Ajarim, A. Ezzat. Rituximab in relapsed/ refractory diffuse large B cell NHL in autologous stem cell transplant setting. 5. D.Ajarim, T Al Twegieri, M. Rahal. Multicenter prospective trial : gulf oncology research group : GORG, in locally advanced breast cancer. 6. S. Kubicka, M. Rahal.Phase III open randomized intergroup efficacy study of the combination of Bevacizumab with cross over fluoro-pyrimidine chemotherapy in patients with metastatic colorectal cancer in progression after first line chemotherapy combined with Bevacizumab. Principal Investigator for the TML ML 18147 phase III Trial